Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxidectin vs Ivermectin for Strongyloides Stercoralis Infection
NCT04848688Phase 3Completed
- Start
- Feb 2022
- Primary completion
- Jul 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of moxidectin in strongyloidiasis. Started Feb 2022; status: completed.
02
Drugs
moxidectin
03
Conditions
strongyloidiasis
Beyond the preview
Go deeper on NCT04848688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04848688.